MMP9 and breast carcinoma: Meanwhile, RUNX2 expression was increased by increasing the expression of vascular endothelial growth factor, matrix metalloproteases (MMP2, MMP9, and MMP13), and bone sialoprotein (BSP) in breast cancer metastatic cells (Dowdy et al., 2010).